Newsfeed

This area is a possible form of presentation for the integration of news sources relating to listed companies.
The presentation level is a template based on short news services, where users can get a quick overview of the latest news. The detailed views enable further research if interested.

This newsfeed is a compilation of current news from direct connections of TopTier NewsWire services related to listed companies. This feed is for demonstration purposes only. Sector-specific news, public relations and product information can be accessed via the GICS portals > Sector Intelligence section.

US4330001060
Reset filter
Do you already know our new terminal view? Click here.
FIGI: BBG00Q53VYM7
HIMS
Hims & Hers Health Inc
GICS: Health Care · SECTOR: EQTY · SUB-SECTOR: Household & Personal Products · THEMEFOLIO: $HLTH
NAME
Hims & Hers Health Inc
ISIN
US4330001060
TICKER
HIMS
MIC
XNYS
REUTERS
HIMS.N
BLOOMBERG
HIMS US
Fri, 04.09.2026       Hims & Hers Health
US4330001060

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Hims To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Hims between August 4, 2025 and July 29, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Thu, 03.09.2026       Hims & Hers Health
US4330001060

New York, New York--(Newsfile Corp. - September 3, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS) on behalf of investors that purchased or otherwise acquired Hims & Hers securities between August 4, 2025 and July...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Thu, 03.09.2026       Hims & Hers Health
US4330001060

SAN FRANCISCO, Sept. 3, 2026 /PRNewswire/ -- Hims & Hers Health, Inc. (NYSE: HIMS) and certain company executives now face a securities class action lawsuit stemming from the FTC's sweeping federal complaint against the company in which the Commission accuses Hims of serious business misconduct....
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Thu, 03.09.2026       Hims & Hers Health
US4330001060

The DJS Law Group reminds investors of a class action lawsuit against Hims & Hers Health, Inc. (“Hims & Hers” or “the Company”) (NYSE: HIMS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Shareholders who purchased shares of HIMS...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Thu, 03.09.2026       Hims & Hers Health
US4330001060

NEW YORK, Sept. 3, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Hims & Hers Health, Inc. ("Hims" or the "Company") (NYSE: HIMS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.      ...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Thu, 03.09.2026       Hims & Hers Health
US4330001060

SAN DIEGO, Sept. 3, 2026 /PRNewswire/ -- Shareholder rights law firm Robbins LLP informs investors that a class action was filed on behalf of all persons and entities who purchased or otherwise acquired Hims & Hers Health, Inc. (NYSE: HIMS) securities between August 4, 2025 and July 29, 2026, inclusive (the "Class Period"). Hims operates a hea...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Thu, 03.09.2026       Hims & Hers Health
US4330001060

Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, informs investors that a securities fraud class action lawsuit has been filed against Hims & Hers Health, Inc. (HIMS) (NYSE: HIMS) on behalf of those who purchased or acquired HIMS securities between August 4, 2025 and July 29, 2026,...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Thu, 03.09.2026       Hims & Hers Health
US4330001060

Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until November 2, 2026 to file lead plaintiff applications in a securities class action lawsuit against Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS), if they...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Thu, 03.09.2026       Hims & Hers Health
US4330001060

SAN DIEGO, Sept. 2, 2026 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Hims & Hers Health, Inc. (NYSE: HIMS) securities between August 4, 2025 and July 29, 2026, inclusive (the "Class Period"), have until November 2, 2026 to seek appointment as lead plaintiff of the Hims & Hers class action...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Thu, 03.09.2026       Hims & Hers Health
US4330001060

Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Hims & Hers Health, Inc. (“Hims & Hers” or “the Company”) (NYSE: HIMS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Secur...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Silent Ad
Wed, 02.09.2026       Hims & Hers Health
US4330001060

NEW YORK, Sept. 2, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Hims & Hers Health, Inc. (NYSE: HIMS) between August 4, 2025 and July 29, 2026, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wis...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Wed, 02.09.2026       Hims & Hers Health
US4330001060

Rosen Law Firm, a global investor rights law firm, announces a class action on behalf of purchasers of securities of securities of Hims & Hers Health, Inc. (NYSE: HIMS) between August 4, 2025 and July 29, 2026. Hims describes itself as a company that “operates a health and wellness platform that connects consumers to licensed healthcare profes...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Wed, 02.09.2026       Hims & Hers Health
US4330001060

The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of shareholders who purchased or otherwise acquired Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS) common stock between August 4, 2025 and July 29, 2026, inclusive (the “Class Period”). Hims & Hers Health, Inc. investors have unt...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Wed, 02.09.2026       Hims & Hers Health
US4330001060

New York, New York--(Newsfile Corp. - September 2, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS).CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATIONIf you are a Hims & Hers investor and have suffered loss...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Wed, 02.09.2026       Hims & Hers Health
US4330001060

Shareholder rights law firm Robbins LLP informs investors that a class action was filed on behalf of all persons and entities who purchased or otherwise acquired Hims & Hers Health, Inc. (NYSE: HIMS) securities between August 4, 2025 and July 29, 2026, inclusive (the "Class Period"). Hims operates a health and wellness platform that connects co...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Tue, 01.09.2026       Hims & Hers Health
US4330001060

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Hims & Hers Health, Inc. (“Hims” or the “Company”) (NASDAQ: HIMS) and reminds investors of the November 2, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Th...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Tue, 01.09.2026       Hims & Hers Health
US4330001060

Glancy Prongay Wolke & Rotter LLP (“GPWR”), announces that it has filed a class action lawsuit in the United States District Court for the Northern District of California, captioned Velanki v. Hims & Hers Health, Inc. et al., 26-cv-09313, on behalf of persons and entities that purchased or otherwise acquired Hims & Hers Health, Inc. (“...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Mon, 31.08.2026       Hims & Hers Health
US4330001060

Hims & Hers Health, Inc. (NYSE: HIMS), the leading global health and wellness platform, today announced it is now serving customers in Australia, marking the company's first-ever presence in the Asia-Pacific market. The entry follows Hims & Hers' acquisition of Eucalyptus earlier this year and begins with the rebrand of Pilot, Eucalyptus'...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Mon, 31.08.2026       Hims & Hers Health
US4330001060

Hims & Hers, the leading global health and wellness platform, today announced it is officially launching the Hims brand in Australia and bringing its personalised care platform to men nationwide. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260831313760/en/ The entry follows Hims...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Mon, 31.08.2026       Hims & Hers Health
US4330001060

New York, New York--(Newsfile Corp. - August 31, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS).CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATIONIf you are a Hims & Hers investor and have suffered losses...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Silent Ad
Fri, 28.08.2026       Hims & Hers Health
US4330001060

New York, New York--(Newsfile Corp. - August 28, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS).CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATIONIf you are a Hims & Hers investor and have suffered losses...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Thu, 27.08.2026       Hims & Hers Health
US4330001060

NEW YORK, Aug. 27, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Hims & Hers Health, Inc. ("Hims" or the "Company") (NYSE: HIMS).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Wed, 26.08.2026       Hims & Hers Health
US4330001060

SAN FRANCISCO, Aug. 26, 2026 /PRNewswire/ -- On July 29, 2026, investors in Hims & Hers Health, Inc. (NYSE: HIMS) saw the price of their shares slide about 14% lower on news that the FTC sued the company over alleged improper business practices. The events have prompted national...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Wed, 26.08.2026       Hims & Hers Health
US4330001060

New York, New York--(Newsfile Corp. - August 26, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS).CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATIONIf you are a Hims & Hers investor and have suffered losses...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Wed, 26.08.2026       Hims & Hers Health
US4330001060

Philadelphia, Pennsylvania--(Newsfile Corp. - August 26, 2026) - National plaintiffs' law firm Berger Montague PC announces an investigation into the Board of Directors of Hims & Hers Health, Inc. (NYSE: HIMS) ("Hims & Hers" or the "Company") for potential breaches of fiduciary duties owed to the Company and its shareholders. The investigat...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Mon, 24.08.2026       Hims & Hers Health
US4330001060

RADNOR, Pa., Aug. 24, 2026 /PRNewswire/ -- Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, is investigating potential violations of the federal securities laws by Hims & Hers Health, Inc. (NYSE: HIMS) on behalf of investors who purchased or acquired Hims & Hers Health, Inc. sec...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Mon, 24.08.2026       Hims & Hers Health
US4330001060

New York, New York--(Newsfile Corp. - August 24, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS).CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATIONIf you are a Hims & Hers investor and have suffered losses...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Mon, 24.08.2026       Hims & Hers Health
US4330001060

Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of Hims & Hers Health, Inc. (NYSE: HIMS) failed to manage Hims & Hers in an acceptable manner, breaching their fiduciary duties to Hims & Hers, and whether Hims & Hers and its shareholders have suffered damages as a res...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Fri, 21.08.2026       Hims & Hers Health
US4330001060

New York, New York--(Newsfile Corp. - August 21, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS).CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATIONIf you are a Hims & Hers investor and have suffered losses...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Wed, 19.08.2026       Hims & Hers Health
US4330001060

SAN FRANCISCO, Aug. 19, 2026 /PRNewswire/ -- investors in Hims & Hers Health, Inc. (NYSE: HIMS) saw the price of their shares slide about 14% lower on news that the FTC sued the company over alleged improper business practices. The events have prompted national shareholders right...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Wed, 19.08.2026       Hims & Hers Health
US4330001060

New York, New York--(Newsfile Corp. - August 19, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS).CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATIONIf you are a Hims & Hers investor and have suffered losses...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Wed, 19.08.2026       Hims & Hers Health
US4330001060

Philadelphia, Pennsylvania--(Newsfile Corp. - August 19, 2026) - National plaintiffs' law firm Berger Montague PC announces an investigation into the Board of Directors of Hims & Hers Health, Inc. (NYSE: HIMS) ("Hims & Hers" or the "Company") for potential breaches of fiduciary duties owed to the Company and its shareholders. The investigat...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Wed, 19.08.2026       Hims & Hers Health
US4330001060

RADNOR, Pa., Aug. 18, 2026 /PRNewswire/ -- Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, is investigating potential violations of the federal securities laws by Hims & Hers Health, Inc. (NYSE: HIMS) on behalf of investors who purchased or acquired Hims & Hers Health, Inc. sec...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Mon, 17.08.2026       Hims & Hers Health
US4330001060

New York, New York--(Newsfile Corp. - August 17, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS).CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATIONIf you are a Hims & Hers investor and have suffered losses...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Fri, 14.08.2026       Hims & Hers Health
US4330001060

New York, New York--(Newsfile Corp. - August 14, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS).CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATIONIf you are a Hims & Hers investor and have suffered losses...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Thu, 13.08.2026       Hims & Hers Health
US4330001060

The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices.[LEARN MORE ABOUT THE INVESTIG...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Wed, 12.08.2026       Hims & Hers Health
US4330001060

RADNOR, Pa., Aug. 12, 2026 /PRNewswire/ -- Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, is investigating potential violations of the federal securities laws by Hims & Hers Health, Inc. (NYSE: HIMS) on behalf of investors who purchased or acquired Hims & Hers Health, Inc. sec...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Wed, 12.08.2026       Hims & Hers Health
US4330001060

New York, New York--(Newsfile Corp. - August 12, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS).CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATIONIf you are a Hims & Hers investor and have suffered losses...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Wed, 12.08.2026       Hims & Hers Health
US4330001060

PHILADELPHIA, Aug. 12, 2026 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces an investigation into the Board of Directors of Hims & Hers Health, Inc. (NYSE: HIMS) ("Hims & Hers" or the "Company") for potential breaches of fiduciary duties owed to the Company and its shareholders. The investigation is focused on wh...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Tue, 11.08.2026       Hims & Hers Health
US4330001060

New York, New York--(Newsfile Corp. - August 11, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS).CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATIONIf you are a Hims & Hers investor and have suffered losses...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Mon, 10.08.2026       Hims & Hers Health
US4330001060

Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”, NYSE: HIMS), the leading global health and wellness platform, today announced financial results for the second quarter ended June 30, 2026. “Hims & Hers is delivering a world-class health experience at a global scale and a reasonable price for the nearly 3 million people who r...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Mon, 10.08.2026       Hims & Hers Health
US4330001060

Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of Hims & Hers Health, Inc. (NYSE: HIMS) failed to manage Hims & Hers in an acceptable manner, breaching their fiduciary duties to Hims & Hers, and whether Hims & Hers and its shareholders have suffered damages as a res...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Mon, 10.08.2026       Hims & Hers Health
US4330001060

New York, New York--(Newsfile Corp. - August 10, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS).CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATIONIf you are a Hims & Hers investor and have suffered losses...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Fri, 07.08.2026       Hims & Hers Health
US4330001060

New York, New York--(Newsfile Corp. - August 7, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS).CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATIONIf you are a Hims & Hers investor and have suffered losses,...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Thu, 06.08.2026       Hims & Hers Health
US4330001060

Hims & Hers, the leading health and wellness platform, today announced a first-of-its-kind* intelligent care experience that puts AI directly inside customers’ care, not on the sidelines of it. Rolling out first to Hers weight loss members, this proactive care experience delivers personalized guidance, real-time attention to her progress, and...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Wed, 05.08.2026       Hims & Hers Health
US4330001060

RADNOR, Pa., Aug. 5, 2026 /PRNewswire/ -- Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, is investigating potential violations of the federal securities laws by Hims & Hers Health, Inc. (NYSE: HIMS) on behalf of investors who purchased or acquired Hims & Hers Health, Inc. secu...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Wed, 05.08.2026       Hims & Hers Health
US4330001060

Philadelphia, Pennsylvania--(Newsfile Corp. - August 5, 2026) - National plaintiffs' law firm Berger Montague PC announces an investigation into the Board of Directors of Hims & Hers Health, Inc. (NYSE: HIMS) ("Hims & Hers" or the "Company") for potential breaches of fiduciary duties owed to the Company and its shareholders. The investigati...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Tue, 04.08.2026       Hims & Hers Health
US4330001060

New York, New York--(Newsfile Corp. - August 3, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS).CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATIONIf you are a Hims & Hers investor and have suffered losses,...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Mon, 03.08.2026       Hims & Hers Health
US4330001060

Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, is investigating potential violations of the federal securities laws by Hims & Hers Health, Inc. (NYSE: HIMS) on behalf of investors who purchased or acquired Hims & Hers Health, Inc. securities and experienced significant financi...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Fri, 31.07.2026       Hims & Hers Health
US4330001060

LOS ANGELES, July 31, 2026 /PRNewswire/ -- Schall, Brown & Schwartz LLP ("SBS"), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Hims & Hers Health, Inc. (" Hims & Hers" or "the Company") (NYSE: HIMS) for violations of the securities laws. INVESTIGATION DETAILS: The inv...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink